Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Genoplan
company
About
Genoplan democratizes healthcare using genomics and deep learning to advance precision medicine and empower informed health decisions.
- New York,New York,United States
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $14M
- Industries
- Artificial Intelligence,Biotechnology,Genetics,Health Care,InsurTech,Life Science,Machine Learning,Predictive Analytics
- Founded date
- Jan 29, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Genoplan Inc.
Genoplan's mission is to democratize healthcare by harnessing the power of population genomics and deep learning. The company is dedicated to making genomics widely accessible, offering tools and analytics that empower individuals to make informed health decisions. Ultimately, Genoplan aims to contribute to the advancement of precision medicine while helping people take control of their well-being.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$19.90M
Genoplan has raised a total of
$19.90M
in funding over 2 rounds. Their latest funding was raised on
Nov 20, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 20, 2018 | Series B | $1M | 3 | — | — | Detail |
| Jun 29, 2018 | Series B | $14M | 3 | — | — | Detail |
| Mar 14, 2016 | Series A | $4.40M | 4 | — | — | Detail |
| Jul 3, 2015 | Seed | $500K | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
9
Genoplan is funded by 9 investors.
Dayli Partners
and Green Cross
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Dayli Partners
|
— | Series B |
Green Cross
|
— | Series B |
PIA Investment Management
|
— | Series B |
DAYLI Financial Group
|
— | Series B |
|
|
— | Series A |
Softbank Ventures Asia
|
— | Series A |
SparkLabs Accelerator
|
— | Series A |
WONIK Investment Partners
|
— | Series A |
CyberAgent
|
— | Seed |
Employee Profiles
Number of Employee Profiles
1
Genoplan has 1 current employee profiles, including
Executive Brian Kang
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
